Adropin/Tirzepatide Combination Mitigates Cardiac Metabolic Aberrations in a Rat Model of Polycystic Ovarian Syndrome, Implicating the Role of the AKT/GSK3β/NF-κB/NLRP3 Pathway.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Adropin/Tirzepatide Combination Mitigates Cardiac Metabolic Aberrations in a Rat Model of Polycystic Ovarian Syndrome, Implicating the Role of the AKT/GSK3β/NF-κB/NLRP3 Pathway.
- Published In:
- International journal of molecular sciences, 26(1) (2024)
- Authors:
- Hegab, Islam Ibrahim, El-Horany, Hemat El-Sayed, Abd-Ellatif, Rania Nagi, Nasef, Nahla Anas, Okasha, Asmaa H, Emam, Marwa Nagy, Hassan, Shereen, Elseady, Walaa S, Radwan, Doaa A, ElEsawy, Rasha Osama, Hafez, Yasser Mostafa, Hassan, Maha Elsayed, Mansour, Nouran Mostafa, Abdelkader, Gamaleldien Elsayed, Fouda, Mohamed H, Abd El Maged, Amira M, Abdallah, Hanan M
- Database ID:
- RPEP-08362
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-08362APA
Hegab, Islam Ibrahim; El-Horany, Hemat El-Sayed; Abd-Ellatif, Rania Nagi; Nasef, Nahla Anas; Okasha, Asmaa H; Emam, Marwa Nagy; Hassan, Shereen; Elseady, Walaa S; Radwan, Doaa A; ElEsawy, Rasha Osama; Hafez, Yasser Mostafa; Hassan, Maha Elsayed; Mansour, Nouran Mostafa; Abdelkader, Gamaleldien Elsayed; Fouda, Mohamed H; Abd El Maged, Amira M; Abdallah, Hanan M. (2024). Adropin/Tirzepatide Combination Mitigates Cardiac Metabolic Aberrations in a Rat Model of Polycystic Ovarian Syndrome, Implicating the Role of the AKT/GSK3β/NF-κB/NLRP3 Pathway.. International journal of molecular sciences, 26(1). https://doi.org/10.3390/ijms26010001
MLA
Hegab, Islam Ibrahim, et al. "Adropin/Tirzepatide Combination Mitigates Cardiac Metabolic Aberrations in a Rat Model of Polycystic Ovarian Syndrome, Implicating the Role of the AKT/GSK3β/NF-κB/NLRP3 Pathway.." International journal of molecular sciences, 2024. https://doi.org/10.3390/ijms26010001
RethinkPeptides
RethinkPeptides Research Database. "Adropin/Tirzepatide Combination Mitigates Cardiac Metabolic ..." RPEP-08362. Retrieved from https://rethinkpeptides.com/research/hegab-2024-adropintirzepatide-combination-mitigates-cardiac
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.